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J Korean Soc Radiol 2015;73(4):240-248 lowed by pathologic examination; however, because of the healing process, it may be difficult to distinguish tissue from a needle biopsy of a pathologic fracture and osteogenic sarcoma (4) . Furthermore, pathologic diagnoses based on needle biopsy may vary by biopsy site, and differ from final diagnoses after surgery. Thus, information obtained by needle biopsy before surgery is limited.
Conventionally, plain radiography is used routinely to detect and evaluate bone tumors, although its abilities to evaluate extraosseous extension and characteristic components of tumors are limited (5) . Computed tomography (CT) scans are particularly useful for detecting bone mineralization, and characterizing pathologic fractures. Magnetic resonance imaging (MRI) can be used to characterize lesions further in terms of tumor extent and extra-osseous extension. In fact, most bone lesions can be diagnosed correctly based on their radiological appearances, and location in bone (6) . However, the differentiation of malignancy and benignity may be difficult in the presence of fractures.
In the current study, we aimed to determine whether benign and malignant bone tumors with an associated pathologic fracture could be differentiated using radiologic findings.
MATERIALS AND METHODS
This study was approved by the Institutional Review Board of our institution. Requirement for informed consent from patients was waived, because of the retrospective nature of the study.
Patients
Bone tumor cases were identified from the electronic archives of MRI examinations of the musculoskeletal system using the search term "pathologic fracture". As a result, 154 cases were identified. However, 76 cases were excluded due to infectious or metabolic conditions, such as, osteomyelitis or osteomalacia, multiple bone masses at the fracture site, cortical disruption by soft-tissue masses or an expansile bony masses (impending fracture), or a bone tumor of diffuse form affecting entire long or short bones. All patients included in this study underwent surgery, and histological findings were obtained. Accordingly, 78 patients (47 men and 31 women, age range: 1-93 years, mean age: 49 years) were enrolled in the present study.
Imaging Methods
All patients underwent plain radiography and CT due to the suspicion of fracture, and all underwent MRI for the evaluation of a space-occupying lesion at the fracture site. MRI was performed at the fracture site. MRI was performed with a field strength of 1.5-3T using a variety of systems. All 78 patients underwent T1-and T2-weighted sequences with variable imaging planes, and gadolinium-enhanced imaging. Fat-suppressed T2weighted sequences were obtained in all cases. Contrast-enhanced images, obtained using the fat-suppression technique, were also available for all patients.
Image Analysis
Images were reviewed by 2 experienced musculoskeletal radiologists (with 3 and 12 years of experience, respectively) who were unaware of either clinical histories or pathologic diagnoses by consensus.
Tumor margins were evaluated on both CT and MR images.
Tumor margins were classified as well-or ill-defined. The later was defined as any indistinct tumor margin. However, margins were investigated around fracture sites, because hematoma formation and edema hindered the assessment of tumor margins at fracture sites. Fracture type was classified as displaced or nondisplaced based on plain radiography, CT, and MRI findings.
For imaging analysis, the following characteristics were considered on MR images; 1) tumor; longest diameter, 2) mass mar- We evaluated the following on CT scans and plain radio- Matrix mineralization and sclerosis were assessed based on presence or absence, and not by pattern or extent.
Statistical Analysis
Data were analyzed using IBM SPSS statistics for windows, version 21 (IBM, Armonk, NY, USA). The significance of differences in the imaging characteristics of malignant and benign bone tumors were determined using Pearson's chi-square test for categorized variables, and the significance of age and size were determined using the 2-sample t-test.
Statistical significance was accepted for p values of < 0.05.
RESULTS
The 78 patients had 22 benign tumors and 56 malignant tumors (types, locations, and numbers of bone tumors were summarized in Table 1 ). The common types of benign bone tumors were giant cell tumor (GCT), aneurysmal bone cyst (ABC), and fibrous dysplasia and the most common malignant type was metastasis. Lung cancer was the most frequent primary cause of metastases (18/51, 35%), followed by hepatocelluar carcinoma (10/51, 19%), breast cancer (4/51, 8%), head and neck cancer (4/51, 8%), gastrointestinal cancer (4/51, 8%), prostatic cancer (3/51, 6%), thyroid cancer (2/51, 4%), bladder cancer (2/51, 4%), cervical cancer (1/51, 2%), renal cell carcinoma (1/51, 2%), cholangiocarcinoma (1/51, 2%), and liposarcoma (1/51, 2%). In the 78 patients, the involved sites were femur (n = 38), humerus (n = 30), tibia (n = 4), clavicle (n = 2), hand (n = 1), radius (n = 1), ulna (n = 1), and fibula (n = 1).
Image analyses findings of benign and malignant pathologic
fractures were shown in Table 2 . Tumor margin, enhancement pattern, and the presence of a sclerotic margin, extra-osseous soft tissue mass, cystic/necrotic/hemorrhagic portions within the mass, displaced fracture, and underlying cortical change were found to significantly differentiate benign and malignant bone (6); humerus (4), femur (2) Plasmacytoma (3); femur (3) Fibrous dysplasia (6); femur (3), humerus (2), tibia (1) Clear cell chondrosarcoma (1); femur (1) Giant cell tumor (2); humerus (1), ulna (1) Lymphoma (1); clavicle (1) Non-ossifying fibroma (1); fibula (1) Enchondroma (1); hand (1) Total = 22 Total = 56 tumors. Tumor size was not related to its benign/malignant status; benign tumors ranged from 2.5 to 12.9 cm (mean; 6.3 cm) and malignant tumors were from 1.3 to 26.8 cm (mean; 7.2 cm).
In cases with a benign pathologic fracture, the more frequently observed radiologic findings included a well-defined tumor margin with a sclerotic rim, no extra-osseous soft tissue mass, more cystic/necrotic/hemorrhagic portions within masses, peripheral rim enhancement or heterogeneous enhancement, underlying cortical change including endosteal scalloping, and a non-displaced fracture (Fig. 1) . In contrast, in malignant pathologic fractures the prominently observed radiologic findings included ill-defined margins, the presence of extra-osseous softtissue mass, more homogeneous enhancement, and a displaced fracture (Fig. 2) . Although benign and malignant pathologic fractures showed no significant gender effect (p = 0.37), they exhibited a significant age effect (cutoff value ≤ 35; sensitivity 100%, specificity 96.4%, p < 0.0001).
Soft tissue edema was observed in all 78 patients. An extra-osseous soft tissue mass was present in 13 patients with a malignant tumor; ten tumors had an ill-defined margin, and the other 3 showed a well-defined soft tissue mass that arose from a bony mass. For mineralization and sclerosis, 1 patient with a malignant bone tumor exhibited calcification within the mass, and 5 showed sclerosis. For periosteal reaction, 1 case with a benign bone tumor showed a single layered pattern, representing benign nature, and all 10 cases with malignant tumors showed an aggressive pattern, such as, hair-on-end, Codman' s triangle, or sunburst types (Fig. 3) . 
DISCUSSION
Sarcoma is commonly associated with pathologic fracture, regardless of age, and this association is often related to a serious pathology (7, 8) . In our cohort, most pathologic fractures were associated with malignant bone tumors (56/78, 72%), especially metastatic bone tumors (51/78, 65%). Pathological fracture of long bones is a common complication of metastatic disease with an incidence of -10% (9-11), but it can also occur in association with benign bone tumors. Therefore, potentially benign aggressive or malignant processes should be biopsied after conducting clinical, radiological, and laboratory evaluations (2) . However, bone tumor biopsy has its limitations, which are mainly related to the method, and to the availability of an experienced musculoskeletal pathologist to correctly interpret findings. Thus, when a portion of the clear outline of a lesion is ill-defined, and the abrupt border separating the lesion from adjacent normal bone is lost, increased biologic activity or even malignant progression should be expected (14) . On the other hand, welldefined margins with a geographic destructive pattern usually indicate benign or slow-growing malignant nature (15) .
Poorly
The presence of an extra-osseous soft tissue mass was also found to significantly differentiate between benign and malignant bone tumors. Benign tumors and tumor-like lesions usually exhibit no soft tissue spread, with the exceptions of GCT and ABC (14, 16) . However, we found no extra-osseous mass in the benign cases included in the study, even in cases of GCT (n = 2) and ABC (n = 6). On the other hand, 14 of the 56 malignant tumors had extra-osseous soft tissue mass, and of these, 4 had a resected specimen of osteosarcoma was associated with a favorable outcome (1) . Therefore, the lack of a necrotic portion and increased cellularity (more homogeneous enhancement) might increase the possibility of malignancy. However, in the present study, a larger cystic/necrotic/hemorrhagic portion showed an increased risk of fracture for benign bone tumors.
Displaced fracture was significantly more common in malignant bone tumors (18/56, 32% vs. 1/22, 4%), indicating that the well-defined margin and 10 an ill-defined margin. These findings were in contrast with those of a previous report, in which malignant tumor masses were described as clear and spread through destroyed cortex while sparing tissue planes (14) .
In the present study, homogeneous enhancement and the ab- The study results indicated that endosteal scalloping was common for benign bone tumors (21/22, 95%), whereas a permeative or 'moth-eaten' pattern was more common for malignant bone tumors (36/58, 62%). In a study by Bui et al. (13) , scalloping was not associated with biological activity, growth, or malignancy.
However, cortical disruption with a permeative pattern on MR images could result from a rapidly growing, more aggressive lesion. Therefore, patterns of underlying cortical changes caused by tumors even in the presence of a pathologic fracture might aid in the differentiation between benign and malignant pathologic fractures.
In the present study, the presence of mineralization or sclerosis with periosteal reaction was not significantly associated with benign/malignant tumor status. However, 10 malignant bone tumors showed aggressive periosteal reactions. Despite the nonspecificity for a particular lesion, these reactions indicated a relationship between a more interrupted and complex pattern and greater biologic activity suggestive of lesions more likely to be aggressive (14) . Periosteal reactions to malignant neoplasms can be identified by "hair-on-end" or "sunburst" patterns or as multilayered zones, such as, "onion-peel" or Codman's triangles (12) . When periosteal reaction is evident, malignant and benign pathologic fractures were accurately differentiated in the present study, as previously reported.
Sex, tumor size, and peritumoral bone marrow edema were not significant differentiating factors between benign and malignant bone tumors. Peritumoral bone marrow and soft tissue edema may develop as reactive changes to bone fracture or cortical disruption. Furthermore, the presence of edema can make tumor characterization difficult, and thus, hinder differentiation. Even for benign bone tumors, especially bone tumors with an expansile nature, such as, non-ossifying fibroma, GCT, ABC, or fibrous dysplasia, the larger lesion size has a greater likelihood of a mechanical defect, and therefore, a higher risk of fracture (1, 2, 16, 17) . Furthermore, when growth is rapid, the cortex around a cyst may be destroyed (1), and thus, tumor size alone may not significantly differentiate between benign and malignant tumors.
This study had some limitations. First, the number of cases was relatively small, and the number of malignant tumors was more than twice that of benign tumors, which is probably because ma-lignant bone tumors have a higher associated risk of pathologic fracture. A larger scale study with a similar number of benign and malignant cases is required for more detailed analyses. Second, the various tumor types and their different distributions among benign and malignant cases might have affected our results. Third, more specific studies to distinguish between benign and malignant tumors, such as, positron emission tomography-CT, MR spectroscopy, elastography, dynamic enhancement, and diffusion weighted MRI could not be performed because of the retrospective nature of this study. Fourth, the methods and the equipment used for the imaging studies differed at the institutions involved, although no problems were encountered during the imaging analyses.
In conclusion, the study showed that significant differentiating criteria between benign and malignant pathologic bone fractures included ill-defined tumor margin, the presence of sclerotic tumor margin and an extra-osseous soft tissue mass, the absence of cystic/necrotic/hemorrhagic portions in a mass, the homogeneous enhancement pattern; and furthermore, the presence of a displaced fracture and of underlying cortical change such as permeative or 'moth-eaten' pattern were suggestive of malignant pathologic fractures. Some imaging findings were found to aid in the differentiation between benign and malignant pathologic fractures. Hence, radiologists should be aware of the above mentioned imaging characteristics in making differential diagnoses.
